4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
US6239121A · kind A · utility
2Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 1999 |
| Grant date | May 29, 2001 |
| Priority date | — |
| Expiry date | Nov 29, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A subject of the invention is the compounds of formula (I): ##STR1## PA1 in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R.sub.1, R.sub.2, R.sub.3, R.sub.4, Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.